Johnson & Johnson

JNJ· NYQ· Healthcare· Drug Manufacturers - General

$272.04

+0.30% Delayed prices.

Johnson & Johnson (JNJ) quarterly earnings

From the Sep 26, 2026 report · Read the full report

Next earnings
Oct 13, 2026

EPS: actual vs expected

Beat estimates in 3 of the last 4 quarters.

QuarterExpectedActualSurprise
Jun 30, 20262.852.9+1.6%
Mar 31, 20262.682.7+0.9%
Dec 31, 20252.462.46-0.1%
Sep 30, 20252.762.8+1.5%

Recent quarters

QuarterRevenueNet incomeDiluted EPS
Jun 30, 202625.31B5.53B2.27
Mar 31, 202624.06B5.24B2.14
Dec 31, 202524.56B5.12B2.1
Sep 30, 202523.99B5.15B2.12
Jun 30, 202523.74B5.54B2.29

Analysts' estimates

Diluted EPSEPS (low - high)RevenueGrowth
Current quarter2.452.31 - 2.6625.29B+5.4%
Next quarter2.972.74 - 3.1326.51B+7.9%
Current fiscal year11.0711.01 - 11.22101.22B+7.5%
Next fiscal year12.1411.3 - 13.47108.72B+7.4%

Frequently asked questions

When does JNJ report earnings?

Johnson & Johnson (JNJ) is expected to report its next results on Oct 13, 2026.

Does JNJ usually beat estimates?

Beat estimates in 3 of the last 4 quarters.

Data as of Sep 29, 2026. Sources: Yahoo Finance (prices, financial statements and analysts' estimates) and the U.S. Treasury (10-year yield). Indicators and valuation are computed without AI.

AI-generated informational content. Not financial advice or a personalised investment recommendation. Investing involves risk, including loss of capital.

Every week, in your inbox

Rating changes, the highest-conviction stocks and the week's best research. Free.

By subscribing you accept the privacy policy. You can unsubscribe at any time.